CHRISTINA FELIZARDO: Open Payments
NPI 1205563418 · NEWTOWN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,101 in 182 payments from 19 companies in 2025. Trend: 2023 $3,061 · 2024 $5,145 · 2025 $7,101
Food & beverage: $5,739Consulting: $1,164Education: $198
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 21 | $1,582 |
| Arcutis Biotherapeutics, Inc. | 5 | $1,182 |
| Janssen Biotech, Inc. | 39 | $1,022 |
| GENZYME CORPORATION | 16 | $628 |
| ABBVIE INC. | 33 | $601 |
| UCB, Inc. | 14 | $414 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $340 |
| Incyte Corporation | 7 | $294 |
| Lilly USA, LLC | 9 | $235 |
| E.R. Squibb & Sons, L.L.C. | 8 | $146 |
Products named: Zoryve, TREMFYA, ANZUPGO, DUPIXENT, ADBRY, Bimzelx, SKYRIZI, EBGLYSS.
Industry payments across CT — which companies pay providers there.
